May 26, 2015

Boehringer Ingelheim Vetmedica, Inc. Announces New Leadership Positions

In efforts to deepen its expertise as a leader in equine and cattle health, Boehringer Ingelheim Vetmedica, Inc. (BIVI) announces Dr. Scott King as the new director of the U.S. Cattle Marketing team, and Amanda McAvoy as senior associate director of the U.S. Equine Marketing team.

"Scott and Amanda bring excellent leadership experience to their new positions," states Steve Boren, executive director of the U.S. Cattle and Equine Business Segments for BIVI. "Their successes in adding value to equine and cattle brands align with our efforts to provide strategic leadership and branding expertise."

Dr. King previously served as the senior associate director of Equine Marketing, and brings 15 years of marketing expertise to his new position. Prior to beginning his career at BIVI, Dr. King also held marketing roles at Land O'Lakes-Purina Feed as well as at Bayer Animal Health as marketing manager of Equine and Pet Products.

Before his marketing career, Dr. King practiced veterinary medicine for 10 years after graduating from the College of Veterinary Medicine at the University of Missouri, Columbia.

McAvoy has served as the north-central cattle region manager with BIVI since January 2013. Previously, she was senior brand manager for Equine Pharmaceuticals, and played a strategic role in the market growth of Prascend® (pergolide mesylate).

Prior to joining BIVI, McAvoy was a product manager for Merial Ltd., where she launched Equioxx® injection and had a role in managing nearly all the company's equine and cattle brands during her six-year term. Preceding her marketing positions, she served as a territory manager for Merial for seven years.

McAvoy holds a bachelor's degree from the University of Missouri, Columbia, in agriculture, with minors in animal science and agricultural economics.